For the Inventor, By the Inventor

Enter inventor name

San Francisco, CA, United States of America

Jay A Nadel

USPTO Granted Patents = 12 (Patent Applications = 1)

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 2.1

ph-index = 8

Forward Citations = 108(Granted Patents)

Company Filing History:

11 out of 15,471

University of California

Genentech, Inc.

where one patent can have more than one assignee

Years Active: 1993-2011

Loading Chart...

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8071074 - Preventing airway mucus production by administration of EGF-R antagonists (2011-12-06),

2. 8048844 - Preventing airway mucus production by administration of EGF-R antagonists (2011-11-01),

3. 7700547 - Preventing airway mucus production by administration of EGF-R antagonists (2010-04-20),

4. 7531500 - Preventing airway mucus production by administration of EGF-R antagonists (2009-05-12),

5. 7358222 - Preventing airway mucus production by administration of EGF-R antagonists (2008-04-15),

6. 7354894 - Preventing airway mucus production by administration of EGF-R antagonists (2008-04-08),

7. 6846799 - Preventing airway mucus production by administration of EGF-R antagonists (2005-01-25),

8. 6566324 - Preventing airway mucus production by administration of EGF-R antagonists (2003-05-20),

9. 6551989 - Preventing airway mucus production by administration of EGF-R antagonists (2003-04-22),

10. 6270747 - In vitro and in vivo assay for agents which treat mucus hypersecretion (2001-08-07),

11. 5403585 - Therapeutic use of enkephalinase (1995-04-04),

12. 5262178 - Therapeutic use of enkephalinase (1993-11-16),

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…